Hofhaus G, Johns D R, Hurko O, Attardi G, Chomyn A
Division of Biology, California Institute of Technology, Pasadena, California 91125, USA. Department of Neurology, The Johns Hopkins Uni.
J Biol Chem. 1996 May 31;271(22):13155-61. doi: 10.1074/jbc.271.22.13155.
Mitochondrial DNA from two genetically unrelated patients carrying the mutation at position 11778 that causes Leber's hereditary optic neuropathy has been transferred with mitochondria into human mtDNA-less rho0206 cells. As analyzed in several transmitochondrial cell lines thus obtained, the mutation, which is in the gene encoding subunit ND4 of the respiratory chain NADH dehydrogenase (ND), did not affect the synthesis, size, or stability of ND4, nor its incorporation into the enzyme complex. However, NADH dehydrogenase-dependent respiration, as measured in digitonin-permeabilized cells, was specifically decreased by approximately 40% in cells carrying the mutation. This decrease, which was significant at the 99.99% confidence level, was correlated with a significantly reduced ability of the mutant cells to grow in a medium containing galactose instead of glucose, indicating a clear impairment in their oxidative phosphorylation capacity. On the contrary, no decrease in rotenone-sensitive NADH dehydrogenase activity, using a water-soluble ubiquinone analogue as electron acceptor, was detected in disrupted mitochondrial membranes. This is the first cellular model exhibiting in a foreign nuclear background mitochondrial DNA-linked biochemical defects underlying the optic neuropathy phenotype.
来自两名携带导致Leber遗传性视神经病变的11778位突变的基因不相关患者的线粒体DNA已与线粒体一起转移到无人类线粒体DNA的rho0206细胞中。在所获得的几种线粒体转移细胞系中分析发现,该突变位于呼吸链NADH脱氢酶(ND)的亚基ND4编码基因中,它不影响ND4的合成、大小或稳定性,也不影响其掺入酶复合物。然而,在用洋地黄皂苷通透处理的细胞中测量的NADH脱氢酶依赖性呼吸作用,在携带该突变的细胞中特异性降低了约40%。这种降低在99.99%置信水平上具有显著性,与突变细胞在含有半乳糖而非葡萄糖的培养基中生长能力的显著降低相关,表明其氧化磷酸化能力明显受损。相反,在破碎的线粒体膜中未检测到使用水溶性泛醌类似物作为电子受体时鱼藤酮敏感的NADH脱氢酶活性降低。这是第一个在异源核背景中表现出线粒体DNA相关生化缺陷的细胞模型,这些缺陷是视神经病变表型的基础。